Skip to main content
. 2012 Apr 24;1(2):e001461. doi: 10.1161/JAHA.112.001461

Figure 2.

Figure 2.

Management of symptomatic late-onset bradycardia after HT. In addition to management of bradycardia, it is imperative to manage possible rejection and significant cardiac allograft vasculopathy. *All symptomatic bradycardia should be considered for biopsy and angiography.